NCT05720585

Brief Summary

This study will be divided into two parts: development of the mobile medical application for older adults with subjective memory decline and the intervention application. Start by developing and optimizing the application based on the rapid prototyping model. Then, in accordance with the framework of designing and evaluating complex intervention measures proposed by the Medical Research Council of the United Kingdom, pre-experiments will be carried out to apply the developed application to the actual intervention process to test the intervention effect, feasibility, and other contents of the application.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 11, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 9, 2023

Completed
6 days until next milestone

Study Start

First participant enrolled

February 15, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

February 9, 2023

Status Verified

January 1, 2023

Enrollment Period

5 months

First QC Date

December 11, 2022

Last Update Submit

February 8, 2023

Conditions

Outcome Measures

Primary Outcomes (4)

  • Subjective Memory Complaint (SMC)

    Subjective Memory Complaint Questionnaire (SMCQ), a SMC self-assessment questionnaire designed for the elderly population, is adopted. There are 14 items in 2 dimensions. The first 4 items are used to evaluate the overall memory and the last 10 items are used to evaluate the daily memory.

    Change from Baseline Subjective Memory Complaint at 1 month

  • Cognitive Function

    Montreal Cognitive Assessment (MoCA) is adopted, which includes 8 aspects of cognitive domain assessment. The total score of this scale is 30 points, the higher the score is, the better the cognitive function will be. .

    Change from Baseline Cognitive function at 1 month

  • Memory

    The Auditory Verbal Learning Test (AVLT), developed by Kwak in 2001, is used to test the verbal memory function of the older adults.

    Change from Baseline Memory at 1 month

  • The Quality of Life Rating Scale (SF-12)

    The Quality of Life Rating Scale (SF-12) is used. There are 12 items in total, with 8 dimensions, which are general health, physiological function, physiological function, physical pain, mental health, vitality, social function and emotional function. The eight dimensions can be summarized into two comprehensive indicators of physical health and mental health.

    Change from Baseline Quality of Life at 1 month

Secondary Outcomes (1)

  • Demographic characteristics

    Base line

Study Arms (1)

Intervention group

EXPERIMENTAL
Other: Intervention of mobile health application

Interventions

According to the contents of the Subjective Memory Complaint (SMC) application intervention program for the older adults previously formulated, the intervention time and the frequency (30min / time, once a week) of each training module and other contents were determined. The application will be implemented and lasted for a total of 1 month.

Intervention group

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with subjective memory complaints by SMCQ for 6 months and above.
  • Individuals age over 60 years (depending on the characteristics of the disease, it can be relaxed to 55 years) are included.
  • Older adults owning and being able to use smartphones to access the Internet, or whose caregivers can assist in the completion can also be included.
  • Older adults who voluntary participate in the study and provide informed consent are also included.

You may not qualify if:

  • Older adults diagnosed with cognitive or mild cognitive impairment.
  • Older adults diagnosed with other neurological disorders ( cerebrovascular disease, encephalitis, brain tumor, brain trauma, epilepsy, Parkinson 's disease, depression, mania, etc. ), metabolic diseases ( anemia, thyroid dysfunction, folic acid and vitamin B12 deficiency, etc. ), carbon monoxide poisoning and cognitive decline caused by general anesthesia
  • Older adults with serious medical and surgical diseases who cannot complete the experiment are also excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Hongli Chen, Master

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Research assistant

Study Record Dates

First Submitted

December 11, 2022

First Posted

February 9, 2023

Study Start

February 15, 2023

Primary Completion

June 30, 2023

Study Completion

December 31, 2023

Last Updated

February 9, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share